High-risk basal cell carcinoma: an update

References

• Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N. Engl. J. Med.353(21), 2262–2269 (2005).
   PubMed Web of Science ®Google Scholar
• Raasch BA, Buettner PG, Garbe C. Basal cell carcinoma: histological classification and body-site distribution. Br. J. Dermatol.155(2), 401–407 (2006).
   PubMed Web of Science ®Google Scholar
• Saldanha G, Fletcher A, Slater DN. Basal cell carcinoma: a dermatopathological and molecular biologic update. Br. J. Dermatol.148(1), 195–202 (2003).
   PubMed Web of Science ®Google Scholar
• Wollina U, Prochnau D, Hoffmann A, Hipler UC, Wetzker R. Vasoactive intestinal peptide and epidermal growth factor: comitogens or inhibitors of keratinocyte proliferation in vitro ? Int. J. Mol. Med.2(6), 725–730 (1998).
   PubMedGoogle Scholar
• Wollina U, Frenkl A, Knöll B, Hipler UC, Wetzker R. Inhibition of signal transduction in EGF-dependent epithelial cell lines. Int. J. Mol. Med.12(4), 673–677 (2003).
   PubMed Web of Science ®Google Scholar
• Kasper M, Schnidar H, Neill GW et al. Selective modulation of Hedgehog/GLI target gene expression by epidermal growth factor signaling in human keratinocytes. Mol. Cell. Biol.26(16), 6283–6298 (2006).
   PubMed Web of Science ®Google Scholar
• Schnidar H, Eberl M, Klingler S et al. Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway. Cancer Res.69(4), 1284–1292 (2009).
   PubMed Web of Science ®Google Scholar
• Lange D, Persson U, Wollina U et al. Expression of TGF-β related Smad proteins in human epithelial skin tumors. Int. J. Oncol.14(6), 1049–1056 (1999).
   PubMedGoogle Scholar
• Bloor BK, Tidman N, Leigh IM et al. Expression of keratin K2e in cutaneous and oral lesions. Association with keratinocyte activation, proliferation, and keratinisation. Am. J. Pathol.162(3), 963–975 (2003).
   PubMedGoogle Scholar
• Sterry W. Guidelines: the management of basal cell carcinoma. Developed by the Guideline Subcommittee of the European Dermatology Forum. Eur. J. Dermatol.16(5), 467–475 (2006).
   PubMedGoogle Scholar
• Walling HW, Fosko SW, Geraminejad PA, Whitaker DC, Arpey CJ. Aggressive basal cell carcinoma: presentation, pathogenesis, and management. Cancer Metastasis Rev.23(3–4), 389–402 (2004).
   PubMed Web of Science ®Google Scholar
• Randle HW. Basal cell carcinoma. Identification and treatment of the high-risk patient. Dermatol. Surg.22(3), 255–261 (1996).
   PubMed Web of Science ®Google Scholar
• Dunn M, Morgan MB, Beer TW. Perineural invasion: identification, significance, and a standardized definition. Dermatol. Surg.35(2), 214–221 (2009).
   PubMedGoogle Scholar
• Geist DE, Garcia-Moliner M, Fitzek MM, Cho H, Rogers GS. Perineural invasion of cutaneous squamous cell carcinoma and basal cell carcinoma: raising awareness and optimizing management. Dermatol. Surg.34(12), 1642–1651 (2008).
   PubMedGoogle Scholar
• Mendenhall WM, Amdur RJ, Hinerman RW. Skin cancer of the head and neck with perineural invasion. Am. J. Clin. Oncol.30(1), 93–96 (2007).
   PubMedGoogle Scholar
• Ansarin H, Daliri M, Soltani-Arabshahi R. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma. Eur. J. Dermatol.16(5), 543–547 (2006).
   PubMed Web of Science ®Google Scholar
• Cohen PR, Schulze KE, Nelson BR. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer. Dermatol. Surg.32(4), 542–551 (2006).
   PubMedGoogle Scholar
• Katz TM, Silapunt S, Goldberg LH, Jih MH, Kimyai-Asadi A. Analysis of 197 female scalp tumors treated with Mohs micrographic surgery. J. Am. Acad. Dermatol.52(2), 291–294 (2005).
   PubMedGoogle Scholar
• Cernea CR, Ferraz AR, de Castro IV et al. Perineural invasion in aggressive skin carcinomas of the head and neck. Potentially dangerous but frequently overlooked. ORL J. Otorhinolaryngol. Relat. Spec.71(1), 21–26 (2009).
   PubMedGoogle Scholar
• Cernea CR, Ferraz AR, de Castro IV et al. Angiogenesis and skin carcinomas with skull base invasion: a case-control study. Head Neck26(5), 396–400 (2004).
   PubMedGoogle Scholar
• Cernea CR, Ferraz AR, de Castro IV et al. Evaluation of basement membrane status in aggressive skin carcinomas with skull base invasion: a case–control study. Ann. Diagn. Pathol.9(3), 130–133 (2005).
   PubMedGoogle Scholar
• Schroeder M, Kestlmeier R, Schlegel J, Trappe AE. Extensive cerebral invasion of a basal cell carcinoma of the scalp. Eur. J. Surg. Oncol.27(5), 510–511 (2001).
   PubMedGoogle Scholar
• Kovarik CL, Stewart D, Barnard JJ. Lethal basal cell carcinoma secondary to cerebral invasion. J. Am. Acad. Dermatol.52(1), 149–151 (2005).
   PubMed Web of Science ®Google Scholar
• Prabhakaran VC, Gupta A, Huilgol SC, Selva D. Basal cell carcinoma of the eyelids. Compr. Ophthalmol. Update8(1), 1–14 (2007).
   PubMedGoogle Scholar
• Soysal HG, Soysal E, Markoç F, Ardiç F. Basal cell carcinoma of the eyelids and periorbital region in a Turkish population. Ophthal. Plast. Reconstr. Surg.24(3), 201–206 (2008).
   PubMed Web of Science ®Google Scholar
• Leibovitch I, McNab A, Sullivan T, Davis G, Selva D. Orbital invasion by periocular basal cell carcinoma. Ophthalmology112(4), 717–723 (2005).
   PubMed Web of Science ®Google Scholar
• Kleydman Y, Manolidis S, Ratner D. Basal cell carcinoma with intracranial invasion. J. Am. Acad. Dermatol.60(6), 1045–1049 (2009).
   PubMedGoogle Scholar
• Wollina U, Helm C, Schreiber A, Brandl H-G. Extensive cranial infiltration by basal cell carcinoma. J. Cutan. Med. Surg.10(5), 257–258 (2006).
   PubMedGoogle Scholar
• Croce A, Moretti A, D’Agostino L, Zingariello P. Orbital exenteration in elderly patients: personal experience. Acta Otorhinolaryngol. Ital.28(4), 193–199 (2008).
   PubMedGoogle Scholar
• Nassab RS, Thomas SS, Murray D. Orbital exenteration for advanced periorbital skin cancers: 20 years experience. J. Plast. Reconstr. Aesthet. Surg.60(10), 1103–1109 (2007).
   PubMed Web of Science ®Google Scholar
• Tyers AG. Orbital exenteration for invasive skin tumours. Eye20(10), 1165–1170 (2006).
   PubMed Web of Science ®Google Scholar
• Rahman I, Cook AE, Leatherbarrow B. Orbital exenteration: a 13 year Manchester experience. Br J. Ophthalmol.89(10), 1335–1340 (2005).
   PubMed Web of Science ®Google Scholar
• Hatano Y, Terashi H, Kurata S et al. Invasion of the lacrimal system by basal cell carcinoma. Dermatol. Surg.25(10), 823–826 (1999).
   PubMedGoogle Scholar
• Wollina U. Epithelial tumours of the outer nose. Indian J. Dermatol.48(2), 194–199 (2003).
   Google Scholar
• Papadopoulos O, Kostopoulos E, Karypidis D, Tsantoulas Z, Moustaki M. Review of nasal reconstruction. J. Craniofac. Surg.20(4), 1072–1077 (2009).
   PubMedGoogle Scholar
• Anthouli-Anagnastopoulou F, Hatziolou E. Recurrent morphean basal cell carcinoma of the skin. A clinico-pathological study of 97 cases. Adv. Clin. Path.6(1), 17–24 (2002).
   PubMedGoogle Scholar
• Motomura H, Taniguchi T, Harada T, Muraoka M, Ishii M. Aggressive basal cell carcinoma in the nasal region. J. Dermatol.32(6), 424–431 (2005).
   PubMedGoogle Scholar
• Garcia L, Nagore E, Llombart B et al. Basal cell carcinoma of the nasolabial fold: an apparently “benign” tumour that often needs complex surgery. J. Eur. Acad. Dermatol. Venereol.20(8), 926–930 (2006).
   PubMedGoogle Scholar
• Lo JS, Snow SN, Reizner GT, Mohs FE, Larson PO, Hruza GJ. Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. J. Am. Acad. Dermatol.25(5 Pt 1), 715–719 (1991).
   Google Scholar
• Mikhail GR, Boulos RS, Knighton RS et al. Cranial invasion by basal cell carcinoma. J. Dermatol. Surg. Oncol.12(5), 459–464 (1986).
   PubMedGoogle Scholar
• Kleydman Y, Manolidis S, Ratner D. Basal cell carcinoma with intracranial invasion. J. Am. Acad. Dermatol.60(6), 1045–1049 (2009).
   PubMedGoogle Scholar
• Farley RL, Manolidis S, Ratner D. Aggressive basal cell carcinoma with invasion of the parotid gland, facial nerve, and temporal bone. Dermatol. Surg.32(2), 307–315 (2006).
   PubMedGoogle Scholar
• Madsen AR, Gundgaard MG, Hoff CM et al. Cancer of the external auditory canal and middle ear in Denmark from 1992 to 2001. Head Neck30(10), 1332–1338 (2008).
   PubMed Web of Science ®Google Scholar
• Müller H, Eisendle K, Gastl G, Höpfl R, Zelger B. Palliative therapy of giant basal cell carcinoma with the monoclonal anti-epidermal growth factor receptor antibody cetuximab. Br. J. Dermatol.158(6), 1386–1388 (2008).
   PubMedGoogle Scholar
• Fantini F, Gualdi G, Cimitan A, Giannetti A. Metastatic basal cell carcinoma with squamous differentiation: report of a case with response of cutaneous metastases to electrochemotherapy. Arch Dermatol.144(9), 1186–1188 (2008).
   PubMedGoogle Scholar
• Caron J, Dereure O, Kerob D, Lebbe C, Guillot B. Metastatic basal cell carcinoma: report of two cases treated with cetuximab. Br. J. Dermatol.161(3), 702–703 (2009).
   PubMed Web of Science ®Google Scholar
• Garcia C, Poletti E, Crowson AN. Basosquamous carcinoma. J. Am. Acad. Dermatol.60(1), 137–143 (2009).
   PubMed Web of Science ®Google Scholar
• Costantino D, Lowe L, Brwon DL. Basosquamous carcinoma – an under-recognized, high-risk cutaneous neoplasm: case study and review of the literature. J. Plast. Reconstr. Aesthet. Surg.59(4), 424–428 (2006).
   PubMedGoogle Scholar
• Uzquiano MC, Prieto VG, Nash JW et al. Metastatic basal cell carcinoma exhibits reduced actin expression. Mod. Pathol.21(5), 540–543 (2008).
   PubMedGoogle Scholar
• Cunneen TS, Yong JL, Benger R. Lung metastases in a case of metatypical basal cell carcinoma of the eyelid: an illustrative case and literature review to heighten vigilance of its metastatic potential. Clin. Experiment Ophthalmol.36(5), 475–477 (2008).
   PubMedGoogle Scholar
• Ting PT, Kasper R, Arlette JP. Metastatic basal cell carcinoma: report of two cases and literature review. J. Cutan. Med. Surg.9(1), 10–15 (2005).
   PubMed Web of Science ®Google Scholar
• Malone JP, Fedok FG, Belchis DA, Maloney ME. Basal cell carcinoma metastatic to the parotid: report of a new case and review of the literature. Ear NoseThroat J.79(7), 511–515, 518–519 (2000).
   Google Scholar
• Von Domarus H, Stevens PJ. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J. Am. Acad. Dermatol.10(6), 1043–1060 (1984).
   PubMed Web of Science ®Google Scholar
• Mabruk MJ, Toh LK, Murphy M, Leader M, Kay E, Murphy GM. Investigation of the effect of UV irradiation on DNA damage: comparison between skin cancer patients and normal volunteers. J. Cutan. Pathol.36(7), 760–765 (2009).
   PubMedGoogle Scholar
• Schulman JM, Fisher DE. Indoor ultraviolet tanning and skin cancer: health risks and opportunities. Curr. Opin. Oncol.21(2), 144–149 (2009).
   PubMed Web of Science ®Google Scholar
• Wollina U. Addiction to tanning – a new cause of early onset of nonmelanoma skin cancer. Open Dermatol. J.3, 86–88 (2009).
   Google Scholar
• Berneburg M. Genodermatosen II. In: Braun-Falco’s Dermatology (3rd Edition). Burgdorf WHC, Plewig G, Wolff HH, Landthaler M (Eds). Springer Medizin Verlag, Heidelberg, Germany, 760–775 (2008).
   Google Scholar
• Crum-Cianflone N, Hullsiek KH, Satter E et al. Cutaneous malignancies among HIV-infected persons. Arch. Intern. Med.169(12), 1130–1138 (2009).
   PubMedGoogle Scholar
• Wilkins K, Turner R, Dolev JC, LeBoit BE, Berger TG, Maurer TA. Cutaneous malignancy and human immunodeficiency virus disease. J. Am. Acad. Dermatol.54(2), 189–206 (2006).
   PubMedGoogle Scholar
• Harwood CA, Proby CM, McGregor JM, Sheaff MT, Leigh IM, Cerio R. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J. Am. Acad. Dermatol.54(2), 290–300 (2006).
   PubMedGoogle Scholar
• Moloney FJ, Comber H, O’Lorcain P, O’Kelly P, Conlon PJ, Murphy GM. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br. J. Dermatol.154(3), 498–504 (2006).
   PubMed Web of Science ®Google Scholar
• Fine JD, Johnson LB, Weiner M, Li KP, Suchindran C. Epidermolysis bullosa and the risk of life-threatening cancers: the national EB Registry experience, 1986–2006. J. Am. Acad. Dermatol.60(2), 203–211 (2009).
   PubMed Web of Science ®Google Scholar
• Griffin JR, Cohen PR, Tschen JA et al. Basal cell carcinoma in childhood: case report and literature review. J. Am. Acad. Dermatol.57(Suppl. 5), S97–S102 (2007).
   Web of Science ®Google Scholar
• Bath-Hextall FJ, Perkins W, Bong J, Williams HC. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst. Rev. (1), CD003412 (2007).
   Google Scholar
• Mosterd K, Krekels GA, Nieman FH et al. Surgical excision versus Mohs’ micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years’ follow-up. Lancet Oncol.9(12), 1149–1156 (2008).
   PubMed Web of Science ®Google Scholar
• Leibovitch I, Huilgol SC, Richards S, Paver R, Selva D. Scalp tumors treated with Mohs micrographic surgery: clinical features and surgical outcome. Dermatol. Surg.32(11), 1369–1374 (2006).
   PubMedGoogle Scholar
• Smeets NW, Kuijpers DI, Nelemans P et al. Mohs’ micrographic surgery for treatment of basal cell carcinoma of the face – results of a retrospective study and review of the literature. Br J. Dermatol.151(1), 141–147 (2004).
   PubMed Web of Science ®Google Scholar
• Smeets NW, Kregels GA, Ostertag JU et al. Surgical excision vs Mohs’ micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet364(9947), 1766–1772 (2004).
   PubMed Web of Science ®Google Scholar
• Essers BA, Dirksen CD, Nieman FH et al. Cost–effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face. Arch. Dermatol.142(2), 187–194 (2006).
   PubMedGoogle Scholar
• Levin F, Khalil M, McCormick SA, Della Rocca D, Maher E, Della Rocca RC. Excision of periocular basal cell carcinoma with stereoscopic microdissection of surgical margins for frozen-section control: report of 200 cases. Arch. Ophthalmol.127(8), 1011–1015 (2009).
   PubMedGoogle Scholar
• Morris DS, Elzaridi E, Clarke L, Dickinson AJ, Lawrence CM. Periocular basal cell carcinoma: 5-year outcome following Slow Mohs surgery with formalin-fixed paraffin-embedded sections and delayed closure. Br. J. Ophthalmol.93(4), 474–476 (2009).
   PubMed Web of Science ®Google Scholar
• Lawrence CM, Haniffa M, Dahl MG. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data. Br. J. Dermatol.160(3), 573–580 (2009).
   PubMedGoogle Scholar
• Lackey PL, Sargent LA, Wong L, Brezienski M, Kennedy JW. Giant basal cell carcinoma surgical management and reconstructive challenges. Ann. Plast. Surg.58(3), 250–254 (2007).
   PubMedGoogle Scholar
• Bovill E, Banwell PE, Teot L et al. ; International Advisory Panel on Topical Negative Pressure. Topical negative pressure wound therapy: a review of its role and guidelines for its use in the management of acute wounds. Int. Wound J.5(4), 511–529 (2008).
   PubMedGoogle Scholar
• Pompucci A, Rea G, Farallo E, Salgarello M, Campanella A, Fernandez E. Combined treatment of advanced stages of recurrent skin cancer of the head. J. Neurosurg.100(4), 652–658 (2004).
   PubMedGoogle Scholar
• Osborne RF, Shaw T, Zandifar H, Kraus D. Elective parotidectomy in the management of advanced auricular malignancies. Laryngoscope118(12), 2139–2145 (2008).
   PubMed Web of Science ®Google Scholar
• Lai SY, Weinstein GS, Chalian AA, Rosenthal DI, Weber RS. Parotidectomy in the treatment of aggressive cutaneous malignancies. Arch. Otolaryngol. Head Neck Surg.128(5), 521–526 (2002).
   PubMedGoogle Scholar
• Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basal cell carcinoma treated with Mohs surgery in Australia III: perineural invasion. J. Am. Acad. Dermatol.53(5), 458–463 (2005).
   PubMedGoogle Scholar
• Williams LS, Mancuso AA, Mendenhall WM. Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis. Int. J. Radiat Oncol. Biol. Phys.49(4), 1061–1069 (2001).
   PubMed Web of Science ®Google Scholar
• Kwan W, Wilson D, Moravan V. Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin. Int. J. Radiat. Oncol. Biol. Phys.60(2), 406–411 (2004).
   PubMed Web of Science ®Google Scholar
• Tomé WA, Jaradat HA, Nelson IA, Ritter MA, Mehta MP. Helical tomotherapy: image guidance and adaptive dose guidance. Front. Radiat. Ther. Oncol.40, 162–178 (2007).
   PubMedGoogle Scholar
• Montgomery L, Macpherson M, Gerig L et al. Simultaneous treatment of multiple basal cell carcinoma lesions. Br. J. Radiol.81(972), e290–e292 (2008).
   Google Scholar
• Chawla SP, Benjamin RS, Ayala AG, Carrasco CH, Hong WK, Martin RG. Advanced basal cell carcinoma and successful treatment with chemotherapy. J. Surg Oncol.40(1), 68–72 (1989).
   PubMed Web of Science ®Google Scholar
• Guthrie TH Jr, Porubsky ES, Luxenberg MN, Shah KJ, Wurtz KL, Watson PR. Cisplatin-based chemotherapy in advanced basal and squamous cell carcinomas of the skin: results in 28 patients including 13 patients receiving multimodality therapy. J. Clin. Oncol.8(2), 342–346 (1990).
   PubMed Web of Science ®Google Scholar
• Barceló R, Viteri A, Muñoz A, Gil-Negrete A, Rubio I, López-Vivanco G. Paclitaxel for progressive basal cell carcinoma. J. Am Acad Dermatol.54(Suppl. 2), S50–S52 (2006).
   Google Scholar
• Turan A, Saricaoglu H, Baskan EB, Toker SC, Tunali S. Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNα-2b and topical imiquimod 5% cream. Int. J. Dermatol.48(2), 201–217 (2009).
   PubMedGoogle Scholar
• Wollina U, Hansel G, Koch A, Köstler E. Oral capecitabine plus subcutaneous interferon alpha in advanced squamous cell carcinoma of the skin. J. Cancer Res. Clin. Oncol.131(5), 300–304 (2005).
   PubMed Web of Science ®Google Scholar
• Lurje G, Lenz HJ. EGFR signaling and drug discovery. Oncology77(6), 400–410 (2009).
   PubMed Web of Science ®Google Scholar
• Stanton BZ, Peng LF. Small-molecule modulators of the Sonic Hedgehog signaling pathway. Mol. Biosyst.6(1), 44–54 (2010).
   PubMed Web of Science ®Google Scholar
• Von Hoff DD, LoRusso PM, Rudin CM et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N. Engl. J. Med.361(12), 1164–1172 (2009).
   PubMed Web of Science ®Google Scholar
• Doggrell SA. The hedgehog pathway inhibitor GDC-0449 shows potential in skin and other cancers. Expert Opin. Investig. Drugs19(3), 451–454 (2010).
   PubMed Web of Science ®Google Scholar
• Byrne CM, Thompson JF. Role of electrochemotherapy in the treatment of metastatic melanoma and other metastatic and primary skin tumors. Expert Rev. Anticancer Ther.6(5), 671–678 (2006).
   PubMed Web of Science ®Google Scholar
• Wagenblast J, Baghi M, Helbig M et al. Craniofacial reconstructions with bone-anchored epithesis in head and neck cancer patients – a valid way back to self-perception and social reintegration. Anticancer Res.28(4C), 2349–2352 (2008).
   PubMed Web of Science ®Google Scholar
• Gentile P, Bottini DJ, Gravante G, Nicoli F, Caruso R, Cervelli V. The use of bone-anchored implants for absent ear. J. Craniofac. Surg.19(3), 744–747 (2008).
   PubMed Web of Science ®Google Scholar
• Cervelli V, Bottini DJ, Arpino A et al. Orbital reconstruction: bone-anchored implants. J. Craniofac. Surg.17(5), 848–853 (2006).
   PubMed Web of Science ®Google Scholar